Print Page |  E-mail Page |  Financial Tear Sheet

Webcast Gilead Sciences at Cowen and Company Healthcare Conference (Replay) 03/11/10 at 10:20 a.m. ET

Gilead Sciences at Cowen and Company Healthcare Conference Thursday, March 11, 2010 10:20 a.m. ET   Webcast Presentation Help   Click here for webcast   Click here for webcast

Receive E-mail Alerts

Date Title   03/04/10 Gilead Sciences to Present at the Cowen and Company 30th Annual Health Care Conference on Thursday, March 11 02/22/10 U.S. Food and Drug Administration Approves Cayston(R) (Aztreonam for Inhalation Solution) for the Improvement of Respiratory Symptoms in Cystic Fibrosis Patients with Pseudomonas Aeruginosa 02/17/10 Gilead's Single-Tablet "Quad" Regimen for HIV Achieves a High Rate of Virologic Suppression in Phase II Study 02/02/10 Gilead Sciences to Present at the 12th Annual BIO CEO Investor Conference on Tuesday, February 9 01/29/10 Gilead Announces Share Repurchase Program 01/28/10 Per Wold-Olsen Joins Gilead Sciences' Board of Directors 01/27/10 Gilead Sciences Announces Notification of ANDA Filing for Viread® 01/26/10 Gilead Sciences Announces Record Fourth Quarter and Full Year 2009 Financial Results 01/19/10 Gilead Sciences to Release Fourth Quarter and Year End 2009 Financial Results on Tuesday, January 26, 2010 01/06/10 Phase II Clinical Trial of Gilead's Investigational Integrase-Based, Once-Daily, Fixed-Dose "Quad" Regimen Meets 24-Week Primary Objective 01/04/10 Gilead Sciences to Present at Two Upcoming Investor Conferences

The information in these news pages should not be deemed accurate or current except as of the date of the particular press release or posting. Gilead has no intention of updating and specifically disclaims any duty to update the information in the press releases. The press releases may contain forward-looking statements. Actual results could vary dramatically as a result of known and unknown risks and uncertainties.